Clearside Biomedical, Inc.
Clearside Biomedical, Inc. (CLSD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLSD · as of Jun 8, 2026
Key Statistics
Explore Clearside Biomedical, Inc. Data
clsd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 62.5%
Competitors & Peers
clsd competitorsCLSD
ALLR
CASI
CING
ENTO
KAPAStock Performance
Full HistoryAbout Clearside Biomedical, Inc.
Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to pioneering novel drug delivery methods to the posterior segment of the eye via the suprachoroidal space. Its commercial product, …
what is clearside biomedical, inc. · clsd stock overview · clearside biomedical, inc. company profile · who is clearside biomedical, inc. ceo · clsd NASDAQ · clearside biomedical, inc. headquarters · clearside biomedical, inc. business segments
About Stock Overview & Key Data
Clearside Biomedical, Inc. (CLSD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 2, 2016. As of the latest trading session, CLSD stock price is $0.41, with a market capitalization of $2.1M. The stock has returned -96.43% over the past 12 months and -45.33% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Clearside Biomedical, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Clearside Biomedical, Inc. reported revenue of $1.7M and net income of -$34.4M. For detailed data — including Clearside Biomedical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Clearside Biomedical, Inc. (CLSD) stock price is $0.41. The stock is traded on NASDAQ under the ticker symbol CLSD. The 52-week range is $0.31 – $17.10.